Exlservice Holdings

EXLS · NASDAQ

$40.86+$1.10 (+2.77%)TodayMarket closed · Oct 20, 4:51 PM ET

Prev close $39.76

EXLS analyst rating

BuyConsensus of 7 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy7
Hold0
Underperform0
Sell0

12-month price target · 11 analysts

Average $44.98 (+10.1% upside)

Low: $39.39
Now: $40.86
High: $48.30

Upgrades and downgrades

The latest rating actions, newest first

EXLS analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
TD Cowen	Aug 27, 2026	Maintains	Buy	$43.00 → $45.00	52%
Baird	Jul 30, 2026	Upgrade	Neutral → Outperform	$35.00 → $45.00	66%
Needham	Jul 29, 2026	Maintains	Buy	$40.00 → $45.00	45%
TD Cowen	Jul 9, 2026	Maintains	Buy	$45.00 → $39.00	52%
Barrington Research	Jun 25, 2026	Maintains	Outperform	$40.00	50%
Barrington Research	Apr 30, 2026	Upgrade	Market Perform → Outperform	$40.00	50%
JP Morgan	Apr 30, 2026	Maintains	Overweight	$42.00 → $43.00	43%
TD Cowen	Feb 26, 2026	Maintains	Buy	$51.00 → $45.00	67%
Stifel	Feb 26, 2026	Maintains	Buy	$54.00 → $46.00	55%
Needham	Feb 26, 2026	Maintains	Buy	$55.00 → $40.00	45%

The case for and against

Updated Aug 18, 2026

Bull case

ExlService Hldgs is expected to benefit from its diverse range of services in the insurance, healthcare, banking, and international markets, as well as its strong focus on data analytics and AI technology. Despite potential risks, the company's performance and financial strength make it a promising investment for long-term growth. By expanding its services to new industries and investing in cutting-edge technology, ExlService Holdings Inc. is poised for continued success and outperformance in the market.

Bear case

ExlService Hldgs is facing pressure in its key verticals such as insurance, healthcare, and banking, resulting in slower growth and margin pressure. Although management's initial guidance for 2026 is conservative, the projected deceleration in growth and flat Y/Y margins raise concerns about the company's ability to maintain its momentum. With a price target of $40 and a P/E multiple of 16x our FY27 EPS estimate, the stock may be overvalued given the current industry trends.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.